Clinical Development

Understand clinical trials, development strategy and regulatory pathways shaping drug approval.

Nicole Dale

Optimising Clinical Trial Data Collection for Better Decisions

Optimising clinical trial data collection Pharmatica image representing fit-for-purpose evidence generation.

Learn how optimised clinical trial data collection improves data quality, reduces protocol and patient burden, and supports smarter clinical development.

Nicole Dale

FAST-EU Pilot: Can Europe Finally Accelerate Multinational Clinical Trials?

Pharmatica image representing the FAST-EU Pilot supporting multinational clinical trials through coordinated European regulatory collaboration, accelerating clinical trial approvals under the EU Clinical Trials Regulation (CTR).

The FAST-EU Pilot aims to accelerate multinational clinical trials through faster coordinated assessments, supporting Europe’s 2030 clinical research ambitions.

Nicole Dale

One Pivotal Trial for FDA Approval? Success Depends on Trial Design

Pharmatica image of a modern pharmaceutical regulatory affairs workspace representing documentation, compliance, and submission processes essential for FDA drug approval. The scene shows three binders labeled “Regulatory Affairs,” “Submissions,” and “Compliance” on a clean office desk with documents and a pen in the foreground, while a blurred meeting of professionals is visible through a glass wall in the background. The composition conveys administrative precision and regulatory science underpinning.

One pivotal trial for FDA approval could accelerate drug development, reshape clinical trial strategy, and change the pharmaceutical regulatory landscape.

Nicole Dale

Deep Learning in Clinical Trials for 2026 and Beyond

Pharmatica representation of deep learning in clinical trials, especially AI‑driven patient recruitment in clinical trials with a realistic laboratory setting and data visualisations, global site maps, and trial analytics dashboards illustrating machine learning in clinical trials, patient recruitment AI, and adaptive trial design AI.

Deep learning is changing how clinical trials are designed, run, and analysed in 2026. Examine the tools, outcomes, and strategic risks shaping adoption.

Shubhangi Dua

Is AI Quietly Creating a GDPR Crisis in Clinical Research?

Generative AI is transforming clinical trials, but a failure to distinguish between pseudonymised and anonymised data is creating costly regulatory gaps.

Nicole Dale

FDA Master Protocol Guidance for Smarter Clinical Trials

Clinical research laboratory featuring a Master Protocol document, laboratory samples, and digital analytics, representing clinical trial efficiency for precision medicine research under the FDA Master Protocol guidance.

Explore the FDA's Master Protocol guidance and how basket, umbrella, and platform trials can improve clinical trial efficiency, especially in oncology and biologics.

Nicole Dale

Operation TrialBlazer: Can the U.S. Reclaim Clinical Trial Leadership?

Operation TrialBlazer aims to reshape U.S. clinical trials by combining FDA regulatory innovation, digital technologies, and modern trial strategies to reclaim global leadership in pharmaceutical development.

Operation TrialBlazer aims to reignite U.S. clinical development by accelerating trials, modernising FDA oversight, and strengthening pharmaceutical innovation.

Nicole Dale

11 Clinical Trials Defining Pharmaceutical Strategy in 2026

The top 11 clinical trials 2026 highlighting breakthrough pharmaceutical innovations across obesity, gene editing, cardiovascular disease, psychiatry, and rare diseases.

We've mapped the competitive, regulatory, and commercial stakes of the top 11 clinical trials that have defined pharma strategy so far in 2026.

Nicole Dale

Real-Time Clinical Trials Are a Huge Competitive Advantage

Clinical researcher analysing live clinical trial dashboards and digital analytics, illustrating real-time clinical trials, continuous clinical trial data monitoring, adaptive trial management, and data-driven decision-making in pharmaceutical research.

Real-time clinical trials enable continuous data capture and faster decisions, improving how data is used in clinical trials. Here is what pharma leaders need to know.

Nicole Dale

How Low Can They Go? Clinical Trial Success Rates

Clinical laboratory automation platform used in drug development research, illustrating factors that influence Clinical Trial Success Rates, including advanced manufacturing technologies, precision workflows, and pharmaceutical innovation.

Clinical trial success rates have declined sharply over the past 20 years. This analysis examines what the data reveals about the drug approval rate and phase-by-phase attrition.

Nicole Dale

The Future for Decentralised Clinical Trials

A healthcare clinician reviewing data on a tablet next to a doctor graphic, representing decentralised clinical trials pharma strategy.

Decentralised clinical trials promise to transform drug development and pharma strategy. The evidence tells a complex story. Here is what’s working and what still needs to be fixed.

Nicole Dale

Digital Twins in Clinical Trials: Simulating Success Before Enrolment

Digital twins in clinical trials simulate patient outcomes to reduce risk and accelerate timelines. Learn how sponsors use them for predictive trial design.

Content type